Delbarre, F., Le Go, A., and Kahan, A. (1975) . Annals of the Rheumatic Diseases, 34, 422-430. Hyperbasophilic immunoblasts in circulating blood in chronic inflammatory rheumatic and collagen diseases. The number of large circulating hyperbasophilic mononuclear cells-referred to as hyperbasophilic immunoblasts (HBI)-is often increased in collagen diseases and rheumatoid arthritis (RA) and grossly reflects the degree of disease activity. In contrast, in psoriatic arthropathy the percentage of HBI is within the normal range. HBI are mainly involved in immune reactions and may provide a valuable routine test for the assessment of the latter in disease states and for the prediction of relapse in chronic collagen diseases.
Immunofluorescent techniques applied to samples from active autoimmune diseases have shown that a number of HBI are Ig-producing B-blasts. Moreover, in a few cases these intracytoplasmic immunoglobulins exhibited a rheumatoid factor-like activity, a finding which promises to yield additional information on the immunopathogenesis of RA.
In 1965 a patient was observed (by F.D.; Richard, 1975) with severe Fiessinger-Leroy-Reiter's syndrome in whom up to 5 % of the circulating leucocytes were hyperbasophilic mononuclear cells of the lymphoplasmocytoid type with mitotic figures. Since then we have studied these cells in over 230 patients with various forms of rheumatic disease.
Hyperbasophilic immunoblasts (HBI) can be detected readily in smears of leucocyte concentrates, and stain well (May-Griinwald-Giemsa), with a spongy and strongly basophilic (or pyroninophilic) cytoplasm; the nucleus is usually eccentric, the nuclear-cytoplasmic ratio high, and the diameter 20-30 pm (Fig. 1) . These atypical mononuclear cells, first described by Turk (1898), have been frequently seen in human blood during the course of bacterial (Gump and Fekety, 1967) or viral infections, such as infectious mononucleosis (Downey and McKinlay, 1923; Litwins and Leibowitz, 1951; Frank and Dougherty, 1953; Wood and Frenkel, 1967) , although their significance was not at first realized.
In the present study circulating hyperbasophilic mononuclear cells have been estimated, using mor Only patients with definite disease, whether acute or in remission, according to clinical and biological criteria, were included in this study. All SLE patients and some of the RA patients were receiving corticosteroid therapy. Ten patients who were treated with chlorambucil (8-10 mg daily) were studied separately. The criteria used to identify HBI were the intense basophilia ofthe cytoplasm and the leptochromatic pattern of the nucleus which showed one or two nucleoli (more clearly seen in phase microscope). They were 1-5 to 3 times the diameter of a small lymphocyte and had the nuclear-cytoplasmic ratio of large lymphocytes (Fig 1) .
Staining with methyl-green-pyronine indicated a high content of RNA in their cytoplasm and nucleus.
In HBI-rich samples, mitotic figures were often seen and the proliferative potential ofHBI was occasionally assessed using a flash-labelling technique with 3H-thymidine (CEN Saclay, France) by incubating 106 lymphocytes (for 1 h at 37°C) in 1 ml autologous plasma and 1 ,Ci isotope.
Radioautography of methanol fixed smears was done by dipping the slides in Ilford K5 nuclear emulsion. These were developed 12 days later in Microdol-X (for 5 min at 20°C) and stained through the emulsion with Giemsa stain. Only qualitative estimations were done, attention being focused on HBI which were found to be heavily labelled. HBI were easily identified with the electron microscope. In the least differentiated cells the cytoplasm showed many ribosomal clusters and a small amount of ergastoplasm (Fig. 2a) ; the nuclear chromatin was scanty or clumped. In those cells judged to be more differentiated, the ergastoplasm was well developed and showed some orientation around the nucleus (Fig. 2b Peripheral blood lymphocytes were isolated by FicollContrix density flotation, washed in Hanks's medium and cell films were prepared on a cytocentrifuge (Shandon). Acetone-fixed smears were stained using an indirect technique. They were first incubated with monospecific goat antisera (Meloy Laboratory), were thoroughly washed, and then incubated with a fluorescein-isothiocyanate conjugated rabbit antigoat-lgG antiserum (FITCRaGG, Hyland Laboratory), washed again, and mounted in buffered glycerol. The antisera or conjugates were tested by immunoelectrophoresis and the specificity of the immunofluorescent staining was ascertained on human bone marrow samples from patients with paraproteinaemia. All the reactions were performed with the same batches of antisera.
Control reactions included blocking procedures by unconjugated RaGG and incubation with FITC-RaGG alone. When the conjugated sera were used in a dilution of 1: 50, as in the indirect technique, no specific staining was observed; however, by lowering the dilution to 1 :4 a few cells exhibiting cytoplasmic fluorescence were found. Differential counts were made by alternate phase contrast and fluorescent microscopy for the percentage of positive cells, and at least 1000 lymphoid cells were counted.
Thirty patients (22 RA, 8 SLE) and ten normal donors were evaluated for percentage of fluorescent cells, using antihuman antisera (specific for a, y, ,u, K, A), and 17 of these were further investigated using monospecific antiIgA, anti-IgG, anti-IgM, and FITC-RaGG in a dilution of 1:4.
Results
The range of HBI concentration values in each group is given in Table I . In normal subjects the number of HBI never exceeded 5/103 lymphocytes, considered to be the upper limit of normal. All values from patients with degenerative arthritis were normal. In the group with acute viral infections, the percentage of HBI was variable and depended on the day of blood sampling (Fig. 3) the percentage of HBI was always normal whereas ESR was raised in all but four; nine patients had a markedlyraised ESR (range60-100mm) and multiple joint involvement. IMMUNOFLUORESCENT STAINING Cells which were found to fluoresce never showed the morphological features of typical plasma cells, and by alternating phase contrast and fluorescent microscopy they were identified as medium and large HBI. Few, if any, fluorescent cells were observed in the peripheral blood of normal subjects and the percentage correlated well with that of HBI (Table III) . In most RA patients the percentage of fluorescent cells was increased to the same extent as that of HBI, while in SLE patients and in two RA patients fluorescent cells tended to be less numerous than HBI. There was a wide disparity in the relative number of cells positive for IgA, IgG, and IgM (Table IV) , but the number of samples was too small for interpretation.
In RA patients (either seropositive or seronegative: Waaler-Rose test) and in two SLE patients, cells reacting with FITC-RaGG were found and their number did not always correlate with the total number of Ig positive cells. In a few cases, however, they probably represented all the positive cells (Table IV) .
EFFECT OF TREATMENT
Corticosteroids have been found to lower the percentage of HBI in the same way that they influence clinical improvement (Fig. 5a ). This was not true for chlorambucil. In ten patients the percentage of HBI was estimated before treatment and again between 10 (Bond, Fliedner, Cronkite, Rubini, Brecher, and Schork, 1959; Crowther, Fairley, and Sewel, 1969a; Amiel and Schneider, 1971) . The percentage of HBI is often increased in pathological situations where inflammatory and immune reactions occur together, such as acute viral infections and connective tissue diseases. In acute viral infections this increase is transient, going on for 10-15 days, while in connective tissue diseases, particularly in SLE, the HBI level may be high for long periods and grossly reflect the degree of clinical activity. Inflammation alone does not sufficiently explain these results, since patients suffering from psoriatic arthritis, even if associated with acute polyarthritis, have normal HBI values.
Another situation which may involve atypical mononuclear cells in peripheral blood is antigenic stimulation (Rechtchikov and Matsukura, 1962; Cannon and Wissler, 1965; Crowther, Fairley and Sewel, 1969b; Lalla, Vesikari, and Virolainen, 1973) .
Hence, the vigorous HBI response to antilymphocyte globulin therapy may be interpreted as an immune reaction against the horse globulin, despite the lack of direct immunological proof. The observations of Denman and Frenkel (1968) in the rat, and those of Traeger, Revillard, Brochier, Touraine, and Berthoux (1970) in man, agree with this hypothesis. A number of these cells morphologically resemble the large, rapidly dividing hyperbasophilic blasts which are released into the efferent lymph and the thoracic duct by antigenically stimulated lymph nodes (Hall and Morris, 1963; Hall and Morris, 1965; Hall, Morris, Moreno, and Bessis, 1967; Delorme, Hodgett, Hall, and Alexander, 1969; Sprent and Miller, 1971) . In addition to the morphological criteria, as has been noted for the lymph-borne immunoblasts (Cunningham, Smith, and Mercer, 1966; Hummler, Harris, Tomasini, Hechtel, and Farber, 1966; Mandel and Asofsky, 1968; Hall, 1970; Hall, Parry, and Smith, 1971) , blood hyperbasophilic mononuclear cells are capable of producing immunoglobulins (Hullinger and Sorkin, 1963; van Furth, Schmit, and Hijmans, 1966; Hummler and others, 1966; van Furth, 1969) . They may therefore be considered as activated Blymphocytes undergoing differentiation into plasma cells (Gowans and Knight, 1964; Birbeck and Hall, 1967; Hall and others, 1971) . There is some evidence from experimental data that T-blasts too may circulate and differentiate into effector cells of cellular immunity (Hall and others, 1967; Denham, Hall, Wolf, and Alexander, 1969; Sprent and Miller, 1971) and possibly into memory cells (Sprent and Miller, 1972) .
The development of radioautography has shown that these cells have a proliferative potential, since they synthesize DNA as they circulate in the blood (Bond and others, 1959; Carter, 1965; Epstein and Brecher, 1965) . They were found to be a heterogeneous group both morphologically and by labelling with 3H-thymidine (Bond and others, 1959; Wood and Frenkel, 1967) , which increases in number under certain conditions of haemopoietic stress (Bond, Fliedner, and Andrews, 1961; Harris, Haigh, and Kugler, 1963; Harris and Kugler, 1971) and may include multipotent stem cells (Barnes and Loutit, 1967) . From these findings it is assumed that the occurrence of hyperbasophilic mononuclear cells in the peripheral blood is related more to immune reactions than to inflammation and this hypothesis is supported by the work of others (Crowther and others, 1969b; Lalla and others, 1973) . Consistent with this possibility are the following observations.
(1) Cells with the ultrastructure of the lymph-borne immunoblasts seen in experimental conditions (Hummler and others, 1966; Hall and others, 1967) are found in HBI-rich buffy coat. (2) The increase of HBI is generally accompanied by a corresponding increase of immunoglobulin-producing cells, probably the most differentiated cells observed by electron microscopy. As has been noted in experimental immunization (Hullinger and Sorkin, 1963; Kearney and Halliday, 1965; Hummler and others, 1966) , there is some evidence that in connective tissue diseases B-blasts differentiating into immunoglobulin-secreting cells may circulate in response to some unknown stimulus.
However, the discrepancy between the cytological and immunofluorescent techniques in some cases of SLE and RA raises the question of whether all hyperbasophilic cells are immunoblasts or not. Since the morphological criteria are debatable and since the blood leucocytes form a heterogeneous cell population, other hypotheses should be considered. One possibility is that the hyperbasophilic cells are bonemarrow derived multipotent stem cells (Barnes and Loutit, 1967) , but no data are available (e.g. from bioassays). Another possibility is that they are macrophage precursors liberated from the bone marrow in response to tissue injury. Horwitz and co-workers, studying the proliferative potential of blood mononuclear cells, have shown that macrophages may derive from nonphagocytic 'lymphocytelike cells' (Horwitz, Stastny, and Ziff, 1970; Horwitz and Steagall, 1972) : these DNA synthesizing macrophage precursors are found in large numbers in SLE and RA patients, and they have the morphological features of 'atypical lymphocytes' according to the criteria of Wood and Frenkel (1967) . These results conflict with our results, though there is no direct evidence that the cell we call HBI and the macrophage precursor are identical. Obviously, in morphological terms the HBI are but a subgroup of the proliferating atypical lymphocyte population (Bond and others, 1959; Wood and Frenkel, 1967; personal observations) . Furthermore not all DNA-synthesizing cells differentiate into macrophages (Horwitz and Steagall, 1972) . The moderate increase of hyperbasophilic cells in gout arthropathy, which could be accounted for by the macrophage precursor hypothesis, is no argument against the concept that these cells are immunoblasts, since immune reactions (probably in response to tissue injury) have already been proposed in gout (Howell, Chamberlain, Perry, Torrigliani, and Roitt, 1972) . Moreover, absence of cytoplasmic immunoglobulin is not incompatible with immunological function; nonfluorescent HBI may be either immature B-blasts (a hypothesis consistent with some ultrastructural features) or T-blasts, the function of which is not antibody secretion but perhaps delayed hypersensitivity-type reactions. Circulating T-blasts have been shown in mice (Sprent and Miller, 1971) and in patients with infectious mononucleosis (Sheldon, Papamichail, Hemsted, and Holborow, 1973 Asherson and Allwood, 1972) , to enter homografts (Hall and others, 1967) , and to destroy allogeneic cells in vitro (Denham and others, 1969) . Hall and colleagues have clearly shown that lymph-borne immunoblasts are endowed with a 'messenger function' in the propagation and amplification of the immune response (Hall, 1967 . It is therefore interesting to find cells reacting with rabbit IgG in patients with RA, although further investigations are needed to confirm that they are rheumatoid factor-secreting cells. These preliminary data will be compared with those of Vaughan, Tanimoto, Chihara, and Johnson (1974) , who found plaque-forming cells reacting with rabbit haemolysinsensitized erythrocytes in the peripheral blood of patients with RA. These observations indicate that HBI circulation is a factor in the pathogenesis of RA and presumably of other autoimmune disorders.
From a practical viewpoint the presence of increased numbers of hyperbasophilic mononuclear cells in the peripheral blood indicates underlying immune reactions, and may also allow rapid and simple prediction of relapse in patients with chronic autoimmune disorders. Since the HBI level is normal in psoriatic arthritis, it may be used as a negative criterion for diagnostic purposes. 
